Allergen immunotherapy on the way to product-based evaluation—a WAO statement

Allergen immunotherapy (AIT) is widely used in clinical practice for patients with moderate to severe allergic rhinitis due to inhalant allergens and may be delivered via subcutaneous (SCIT) and sublingual routes (SLIT). However, the quality of evidence for individual AIT products is very heterogene...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The World Allergy Organization journal Ročník 8; číslo 1; s. 29 - 4
Hlavní autori:	Bachert, Claus, Larché, Mark, Bonini, Sergio, Canonica, Giorgio Walter, Kündig, Thomas, Larenas-Linnemann, Desiree, Ledford, Dennis, Neffen, Hugo, Pawankar, Ruby, Passalacqua, Giovanni
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Elsevier Inc 2015 Elsevier BV BioMed Central BioMed Central Ltd Elsevier
Predmet:	Allergens Allergies Allergology Analysis Asthma Care and treatment EUROPE Evidence-based medicine Health aspects Immunologic diseases. Allergy Immunology Immunology and Allergy Immunotherapy Medical colleges Medicine Medicine & Public Health Medicine and Health Sciences ORGANIZATION Position and Guidelines Position Article and Guidelines RANDOMIZED CONTROLLED-TRIAL RC581-607 RECOMMENDATIONS RHINOCONJUNCTIVITIS STANDARDIZATION Allergic Rhinitis Individual Product Allergen Immunotherapy Allergen Extract Inhalant Allergen
ISSN:	1939-4551, 1939-4551
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!